Biliary Leak in Post-Liver-Transplant Patients: Is There Any Place for Metal Stent?

Table 1

Patients demographics.

Type of stent	PCSEMS	FCSEMS with fins	FCSEMS with flare ends
N	3	18	10
Gender
Male	3	15	7
Age
(mean ± SD)	50±8.7	53.9±5.0	56±6.7
Median (range)	40–56	42–60	48–69
Underlying liver disease
HCV		6	4
Ethanol		3	1
Cryptogenic	2	3	2
HCV + ethanol		2	2
HBV		1
NASH	1	1	1
Other		2
Post-OLT leak location
Anastomotic	1 (33.3%)	14 (77.8%)	7 (70%)
Nonanastomotic	2 (66.7%)	4 (22.2%)	3 (30%)
Time OLT to procedure (days)
Mean (SD)	36 (±8)	53.2 (±85.8)	22.9 (±16.4)
Median (range)	33 (29–45)	20 (6–328)	19 (5–63)
Previous plastic stenting
Yes	100%	3 (16.7%)	2 (20%)
T-tube	0	0	1 (10%)

OLT: orthotopic liver transplant, SD: standard deviation, HCV: hepatitis C virus; HBC: hepatitis B virus; others (hemochromatosis, alpha-1-antitrypsin). PCSEMS: partially covered self-expanding metal stent, FCSEMS: fully covered self-expanding metal stent.